Write in a clean editor, then format for Malignancy Spectrum in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Malignancy Spectrum is a peer-reviewed journal published by Wiley, covering Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Global Cancer Incidence and Screening.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Malignancy Spectrum 12 (3): 45–58.
Formats any DOI in Malignancy Spectrum style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Pancreatic and Hepatic Oncology Research Global Cancer Incidence and Screening Gastric Cancer Management and Outcomes Lung Cancer Diagnosis and Treatment |
| ISSN | 2770-9140 |
| Citation impact (2-yr) | 0.46 |
| h-index | 4 |
| i10-index | 1 |
| Total citations | 54 |
| Top institutions publishing here | Peking University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Radiotherapy (RT) plays a crucial role in tumor treatment and is an indispensable therapeutic approach. However, ionizing radiation often damages the normal tissues surrounding the tumor. Therefore, there is an urgent need for effective methods to improve the precision of RT. Nanotechnology has shown potential in enhancing the efficacy and safety of tumor RT.…
Abstract Gastric cancer (GC) is one of the most common malignancies globally, the occurrence of which undergoes a multistage chronic evolutionary process. It is a great public health issue to deeply understand the mechanisms of GC development and factors affecting the evolution of gastric lesions. Helicobacter pylori infection has been identified as one of the…
Abstract Basic research on heavy ion cancer therapy such as radiobiology, medical physics, and therapeutic technique has been conducted at the Institute of Modern Physics (IMP), Chinese Academy of Sciences since 1995. Based on the achievements acquired in the basic research and the requirements for a heavy ion accelerator for radiotherapy purposes, a dedicated heavy…
Abstract During the process of carcinogenesis and tumor progression, various molecular alternations occur in different omics levels. In recent years, multiomics approaches including genomics, epigenetics, transcriptomics, proteomics, metabolomics, single‐cell omics, and spatial omics have been applied in mapping diverse omics profiles of cancers. The development of high‐throughput technologies such as sequencing and mass spectrometry has…
Abstract Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has radically transformed the field of oncological therapy. However, immune‐related adverse events (irAEs) associated with the treatment might affect the life quality and even threaten the life of cancer patients. Immunotherapy‐mediated colitis (IMC) is one of the most prevalent irAEs, especially in anti‐cytotoxic T lymphocyte antigen 4 antibody…
